Combined Transcranial Sonography of the Substantia Nigra and 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes
Movement Disorders Clinical Practice · 2026-11 · 13 (11) · 2812-2821
DOI: 10.1002/mdc3.70769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 09.08.2026. Verfasst von Tong Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Substantia Nigra, Positron Emission Tomography Computed Tomography, Ultrasonography, Doppler, Transcranial, Parkinsonian Disorders. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AI Medical Research Project of Army Medical Center, Natural Science Foundation of Chongqing, Chongqing Science and Health Joint Medical Research Project.
Abstract (Originalsprache)
Background
Accurate differentiation between Parkinson's disease (PD) and atypical parkinsonian syndromes (APS) remains challenging where dual‐tracer ( 11 C‐2β‐carbomethoxy‐3β‐(4‐fluorophenyl) tropane [[ 11 C]CFT] and 18 F‐fluorodeoxyglucose [[ 18 F]FDG]) positron emission tomography/computed tomography (PET/CT) access is limited.
Objective
The aim was to investigate whether transcranial sonography (TCS) of the substantia nigra (SN) can replace [ 11 C]CFT PET when combined with [ 18 F]FDG PET for diagnosing early PD and differentiating PD from APS.
Methods
Totally 160 patients with suspected PD or APS underwent clinical assessment, SN‐TCS, and PET/CT. PET/CT images were evaluated by visual assessment based on predetermined disease‐specific patterns. Diagnoses of TCS‐SN were performed according to predefined criteria. Diagnostic performance was evaluated using 2 binary comparisons: PD versus non‐PD and APS versus non‐APS.
Results
After a median follow‐up period of 23 months, the final clinical diagnoses were PD (n = 72), APS (n = 50), and parkinsonian syndromes other than PD or APS (n = 33). For diagnosis of PD, combined SN‐TCS with [ 18 F]FDG PET/CT strategy exhibited comparable specificity to dual‐tracer PET/CT (90.4% vs. 95.2%, P = 0.344) but significantly lower sensitivity (34.7% vs. 84.7%, P < 0.001). Compared to TCS alone, the combined approach yielded similar sensitivity (34.7% vs. 36.1%, P = 1.000) and higher specificity (90.4% vs. 72.3%, P < 0.001). For APS diagnosis, this combined approach achieved comparable sensitivity (76.0% vs. 86.0%, P = 0.180), specificity (86.7% vs. 86.7%, P = 1.000), accuracy (83.2% vs. 86.5%, P = 0.302), and the area under the curve (0.81 vs. 0.86, P = 0.115) relative to dual‐tracer PET/CT.
Conclusion
The combination of SN‐TCS and [ 18 F]FDG PET/CT may serve as an effective triage tool for PD with high specificity. For APS, this combined strategy may provide a feasible diagnostic option in settings with limited access to dual‐tracer PET/CT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, China.
- Department of Ultrasound, Daping Hospital, Army Medical University, Chongqing, China.
- Chongqing Clinical Research Center for Imaging and Nuclear Medicine, Chongqing, China.
ORCID-Profile: Jingqin Fang, Xiao Chen
Förderung
- AI Medical Research Project of Army Medical Center
- Natural Science Foundation of Chongqing
- Chongqing Science and Health Joint Medical Research Project
- Science and Technology Innovation Ability Enhancement Project of Army Medical University
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Wu, T., Zhou, Z., Gong, W., Sun, J., Zhou, W., Li, X., Fang, J., & Chen, X. (2026). Combined Transcranial Sonography of the Substantia Nigra and 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes. Movement Disorders Clinical Practice, 13(11), 2812-2821. https://doi.org/10.1002/mdc3.70769
Vancouver
Wu T, Zhou Z, Gong W, Sun J, Zhou W, Li X, et al. Combined Transcranial Sonography of the Substantia Nigra and 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes. Movement Disorders Clinical Practice. 2026;13(11):2812-2821. doi:10.1002/mdc3.70769
BibTeX
@article{Wu2026,
author = {Wu, Tong and Zhou, Ziwei and Gong, Wenjie and Sun, Jinju and Zhou, Weicheng and Li, Xin and Fang, Jingqin and Chen, Xiao},
title = {Combined Transcranial Sonography of the Substantia Nigra and 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes},
journal = {Movement Disorders Clinical Practice},
year = {2026},
volume = {13},
number = {11},
pages = {2812--2821},
doi = {10.1002/mdc3.70769}
}
EUVIMED